News

NEWS

LATEST NEWS

Antibiotic Discontinuation in Neutropenic Patients With Acute Myeloid Leukemia

New Tool for Reconstituting Factor VIII for Hemophilia A Prophylaxis

Consensus Panel on Maintenance Therapies Following Autologous Hematopoietic Cell Transplantation in Lymphoma

Optimal Platelet Transfusion Threshold Unknown in Patients Undergoing Lumbar or Epidural Procedures

Quantifying Adherence to Mucormycosis Treatment Guidelines in Patients With Hematologic Malignancies

Novel Risk Factors for Veno-Occlusive Disease Following Hematopoietic Stem Cell Transplantation

Managing Neonatal Thrombocytopenia of Alloimmune Origin

UPCOMING MEETINGS

December 7 – 10, 2019
American Society of Hematology Annual Meeting and Exposition
Orlando, FL

Click here to view the full calendar

DRUG NEWS FROM MPR

FDA Places Clinical Hold on Venetoclax Trials for Multiple Myeloma

Esperoct Approval Provides New Treatment Option for Hemophilia A

FDA Approves New Administration Option for Darzalex

Crizanlizumab Granted Breakthrough Tx for Sickle Cell Pain Crises Prevention

Sprycel Plus Chemotherapy OK’d to Treat Certain Pediatric Patients With Ph+ ALL

FDA Approval Expands Access to Factor Xa Inhibitor Antidote Andexxa

FDA Approves Updated Labeling for Hemophilia A Treatment Novoeight

Amicar Tablet Generic Gets FDA Approval

FDA: Serious Side Effect of AML Drug Not Being Recognized

First Rituximab Biosimilar Truxima Gets FDA Approval

Next hm-section-front in News

Meetings Calendar